Israel Medica2010 Companies Catalogue - Israeli-South African ...

Common Sense Ltd.
Back to TOC
Company at a Glance
www.cs-commonsense.com
COMMON Sense’s proprietary technologies enable the diagnosis of bacterial vaginosis (BV), trichomoniasis
and amniotic fluid leakage through the non-invasive collection of vaginal secretions on panty–liners as well
as on vaginal swabs.
COMMON SENSE carries out R&D, manufactures and markets non-invasive OTC panty-liner home tests and
OTC and OTC/Rx professional vaginal swabs for gynecologists, point of care and hospitals for the:
1. Classification of common abnormal vaginal discharges and detection of acidity parameters associated
with BV or trichomoniasis in symptomatic women.
VI-SENSE (VI=Vaginal Infections) panty-liner and swabs kit
2. Detection of amniotic fluid leakage.
AL-SENSE (AL=Amniotic Leak) panty-liner kit
3. Monitoring pregnant women with pre-term delivery history for asymptomatic BV infection and reduce
risk of pre-term delivery.
VA–Sense (VA=Vaginal Acidity) panty-liner kit
4. Monitoring pH in asymptomatic women as an early warning for vaginal itching, odors and other
symptoms.
Norma-Sense panty- liner
The company's inventions have been filed as US patents and PCT. The products are FDA and CE approved.
Category, Subcategory & Therapeutic Area(s)
Category:
Subcategory:
Therapeutic Area(s):
Company Status:
Medical Devices
Diagnostic
Gynecology, Women's Health
Initial Revenues
Technology & Product(s)
COMMON SENSE Ltd.'s proprietary technology includes a range of indicator polymers that react with
different pH levels, buffer capacity values, and ammonium ion concentrations by changing color from yellow
to blue green, in the presence of vaginal secretions with elevated pH levels that indicate BV or trichomoniasis
or an amniotic fluid leak.The resulting stain is stable for many hours, while the change in color due to the
contact with urine is reversible.
These kits providee, for the first time, the revolutionary ability to determine non-invasively the cause of
abnormal vaginal discharge, and to identify amniotic fluid leakage. The company believes this technology to
be applicable to a host of novel applications that until now have had no solution.
Goal
Objectives:
Target Businesses:
Target Countries: Worldwide
COMMON SENSE Ltd.'s goal is to become the leading supplier of home and
professional tests for common abnormal discharges, monitoring for abnormal pH
levels, and detection of amniotic fluid leakage, as well as for other gynecological and
urological conditions
17